Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Pyruvate dehydrogenase deficiency and epilepsy.Brain Dev. 2011; 33: 856-865
- Pyruvate dehydrogenase complex deficiency and its relationship with epilepsy frequency--An overview.Epilepsy Res. 2015; 116: 40-52
- Gender-specific occurrence of West syndrome in patients with pyruvate dehydrogenase complex deficiency.Neuropediatrics. 2001; 32: 295-298
- A 1.1 million base pair X-chromosomal deletion covering the PDHA1 and CDKL5 genes in a female patient with West syndrome and pyruvate oxidation deficiency.Neuropediatrics. 2012; 43: 130-134
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.Genet Med. 2015; 17: 405-424
- Vigabatrin - new data on indications and safety in paediatric epilepsy.Neurol Neurochir Pol. 2021; 55: 429-439
Publication stageIn Press Journal Pre-Proof
Financial Disclosure: This work was supported in part by the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED (JP22ek0109468, JP19ek0109273).
Conflict of Interest: The authors have indicated they have no potential conflicts of interest to disclose.